We showed that MK2 conditional deficiency in myeloid lineage cells markedly alleviated pathological damages and decreased the production of inflammatory cytokines, MPO, and ROS in DSS-induced IBD models by using MK2lyz2−KO mice, in which gene expression of MK2 was abolished in the myeloid lineage cells. This evidence concerns the gene MPO and inflammatory bowel disease.